The clinical aspects of using thrombolytic therapy in myocardial infarct at the prehospital stage

Staroverov, I.I.; Dundua, D.P.; Plotnikov, A.N.; Pomerantsev, E.V.; Bliumental', A.A.; Puchkov, A.T.; Ovasapian, I.A.; Serov, V.P.; Ruda, M.I.; Staroverov, I.I; Dundua, D.P; Plotnikov, A.N; Pomerantsev, E.V; Bliumental&apo; , A.A; Puchkov, A.T; Ovasapian, I.A; Serov, V.P; Ruda, M.I

Home

>

Node

>

Subnode

The clinical aspects of using thrombolytic therapy in myocardial infarct at the prehospital stage

Staroverov, I.I.; Dundua, D.P.; Plotnikov, A.N.; Pomerantsev, E.V.; Bliumental', A.A.; Puchkov, A.T.; Ovasapian, I.A.; Serov, V.P.; Ruda, M.I.

Kardiologiia 33(3): 28-32

1993

ISSN/ISBN: 0022-9040

PMID: 8377336

Document Number: 419122

The examination of 80 patients with acute myocardial infarction has revealed that prehospital thrombolytic therapy (TT) allows it to be initiated significantly earlier by 2.9 hours, resulting in coronary reperfusion and ensuring more complete blood flow recovery than hospital therapy. The natural history of the disease is also more favourable when TT is used in the prehospital period. It is concluded that with strict observance of indications and contraindications, TT used by an emergency team in the prehospital period is no more dangerous than in the hospital period.